FDA Drug Application (019967) for ULTRAVATE by RANBAXY

Back to FDA Applications sponsored by RANBAXY

Application Number019967
Product Number001
FormCREAM;TOPICAL
Dosage0.05%
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameULTRAVATE
Active IngredientHALOBETASOL PROPIONATE

Active IngredientCount
List of drugs with Active Ingredient HALOBETASOL PROPIONATE2


Back to FDA Applications sponsored by RANBAXY